Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Clinical trial NCT00210899 · COMPLETED

Trial details

NCT number: NCT00210899
Sponsor: Basilea Pharmaceutica
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Diseases, Infectious Skin Diseases, Bacterial Staphylococcal Skin Infections

Start date: 2005-09-01
Primary completion: 2006-10-01
Enrollment: 828

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.